News & Analysis on Clinical Trial Services & Contract Research And Development
Medicine containers that talk and give instructions on dosing have been discussed for a long time, but the first systematic application of the technology has come from a somewhat unlikely the source - the US Army.
US biotechnology company Corgentech has licensed a peptide delivery technology from UK-based Cyclacel to help it develop a new class of gene blocking drugs.
Chemicals group Lanxess - to be spun out of Germany's Bayer next year - plans to relocate a plant in Texas to China in order to tap into the strong growth in the market for chemicals there.
Danish pharmaceutical company Novo Nordisk has decided to put its weight behind the inhaled insulin project it has been pursuing alongside US drug delivery specialist Aradigm.